Profile
Magnus Hansson is currently the Chief Medical Officer & VP-Preclinical Development at Abliva AB since 2016.
Previously, he worked as an Associate Professor at Skane University Hospital from 2008 to 2015.
Dr. Hansson obtained a doctorate degree from the University of Lund.
Magnus Hansson active positions
| Companies | Position | Start |
|---|---|---|
| ABLIVA AB | Chief Tech/Sci/R&D Officer | 2015-12-31 |
Former positions of Magnus Hansson
| Companies | Position | End |
|---|---|---|
Skane University Hospital
Skane University Hospital Hospital/Nursing ManagementHealth Services Operates as an hospital | Corporate Officer/Principal | 2015-11-30 |
Training of Magnus Hansson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Abliva AB
Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skane University Hospital
Skane University Hospital Hospital/Nursing ManagementHealth Services Operates as an hospital | Health Services |
- Stock Market
- Insiders
- Magnus Hansson
















